Related Experiment Video
Updated: Aug 6, 2026
06:40
Collection of Human Follicular Fluid, Follicle Somatic Cells, and Immature Oocytes from Individuals Undergoing In Vitro Fertilization
Published on: October 24, 2025
Evidence-based follitropin
1Human Reproduction Centre, Hospital de Clinicas de Porto Alegre, universidade Federal do Rio Grande do Sul, Brazil. sabino@via-rs.net
Reproductive Biomedicine Online
|August 10, 2006
Summary
Proper use of gonadotrophin during ovarian stimulation is crucial for improving pregnancy rates. This commentary reviews follitropin preparations (FbM and FbB) and evidence for optimal outcomes.
Area of Science:
- Reproductive Endocrinology
- Infertility Treatments
- Ovarian Stimulation Protocols
Background:
- Gonadotrophin utilization significantly impacts ovarian stimulation success and pregnancy rates.
- Diverse gonadotrophin preparations are available, necessitating informed selection.
- Follitropin preparations, including urinary (FbM) and recombinant (FbB) forms, are key agents.
Discussion:
- This commentary critically evaluates follitropin preparations (FbM and FbB) for ovarian stimulation.
- It synthesizes relevant epidemiological evidence to guide clinical decision-making.
- Optimizing gonadotrophin choice is essential for maximizing treatment efficacy.
Key Insights:
- The choice of gonadotrophin preparation can influence pregnancy outcomes.
- Evidence-based selection of follitropin (FbM vs. FbB) is vital for successful ovarian stimulation.
- Understanding the nuances of different preparations improves patient results.
Outlook:
- Future research should focus on head-to-head comparisons of follitropin preparations.
- Personalized ovarian stimulation protocols incorporating specific gonadotrophins are warranted.
- Continued evaluation of epidemiological data will refine best practices in fertility treatment.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...